Key Record Dates
ClinicalTrials.gov Identifier: | NCT04380805 |
---|---|
Brief Title: | A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer |
First Submitted : | May 1, 2020 |
First Submitted that Met QC Criteria : | May 7, 2020 |
First Posted : | May 8, 2020 |
Last Update Submitted that Met QC Criteria : | October 20, 2022 |
Last Update Posted : | October 21, 2022 |